DC-SIGN gene promoter variants and IVIG treatment response in Kawasaki disease

FcγR gene copy number in Kawasaki disease and intravenous immunoglobulin treatment response

(2013) Robert Makowsky et al.   Pharmacogenetics and Genomics

Role of Activating Fc γ R Gene Polymorphisms in Kawasaki Disease Susceptibility and Intravenous Immunoglobulin Response

(2012) Sadeep Shrestha et al.   Circulation-Cardiovascular Genetics

Naturally-Occurring Genetic Variants in Human DC-SIGN Increase HIV-1 Capture, Cell-Transfer and Risk of Mother-To-Child Transmission

(2012) Geneviève Boily-Larouche et al.   PLoS One

Etanercept as adjunctive treatment for acute kawasaki disease: Study design and rationale

(2011) Michael A. Portman et al.   AMERICAN HEART JOURNAL

Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease

(2011) Sadeep Shrestha et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Kawasaki syndrome: an intriguing disease with numerous unsolved dilemmas

(2011) Fernanda Falcini et al.   Pediatric Rheumatology

DC-SIGN (CD209) Promoter −336 A/G Polymorphism Is Associated with Dengue Hemorrhagic Fever and Correlated to DC-SIGN Expression and Immune Augmentation

(2011) Lin Wang et al.   PLoS Neglected Tropical Diseases

CD209 (DC-SIGN) −336A>G promoter polymorphism and severe acute respiratory syndrome in Hong Kong Chinese

(2010) Kelvin Yuen Kwong Chan et al.   HUMAN IMMUNOLOGY

Polymorphic variants in DC-SIGN, DC-SIGNR and SDF-1 in high risk seronegative and HIV-1 patients in Northern Asian Indians

(2008) Omkar Chaudhary et al.   JOURNAL OF CLINICAL VIROLOGY

Identification of a receptor required for the anti-inflammatory activity of IVIG

(2008) R. M. Anthony et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA